Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...
Emerging antiviral defense systems are expanding the conceptual and practical boundaries of genome editing. Across bacteria, archaea, and eukaryotes, hosts ...
Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /CNW/ - Specific Biologics Inc. ("Specific"), a ...
Morning Overview on MSN
AI-guided CRISPR tool aims to make DNA edits more precise and safer
Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...
Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organisms Patent now opens up ...
Researchers identified hundreds of anti-CRISPR proteins in human gut phages, including a new dual-function family that blocks ...
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a ...
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
Waking up this morning to news of the much-deserved Nobel Prize win for Emmanuelle Charpentier and Jennifer A. Doudna "for the development of a method for genome editing" confirms the importance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results